PortfoliosLab logoPortfoliosLab logo
ONCT vs. SAGE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ONCT vs. SAGE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Oncternal Therapeutics, Inc. (ONCT) and Sage Therapeutics, Inc. (SAGE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ONCT

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*

SAGE

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ONCT vs. SAGE - Yearly Performance Comparison


Fundamentals

Total Revenue (TTM)

ONCT:

$1.67M

SAGE:

$70.41M

Gross Profit (TTM)

ONCT:

-$16.96M

SAGE:

$63.04M

EBITDA (TTM)

ONCT:

-$17.87M

SAGE:

-$302.71M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ONCT vs. SAGE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Oncternal Therapeutics, Inc. (ONCT) and Sage Therapeutics, Inc. (SAGE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ONCT vs. SAGE - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


ONCTSAGEDifference

Sharpe Ratio (All Time)

Calculated using the full available price history

1.68

Drawdowns

ONCT vs. SAGE - Drawdown Comparison


Loading charts...

Drawdown Indicators


ONCTSAGEDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

Current Drawdown

Current decline from peak

0.00%

Average Drawdown

Average peak-to-trough decline

0.00%

Volatility

ONCT vs. SAGE - Volatility Comparison


Loading charts...

Volatility by Period


ONCTSAGEDifference

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

Dividends

ONCT vs. SAGE - Dividend Comparison

Neither ONCT nor SAGE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ONCT vs. SAGE - Financials Comparison

This section allows you to compare key financial metrics between Oncternal Therapeutics, Inc. and Sage Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0
31.66M
(ONCT) Total Revenue
(SAGE) Total Revenue
Values in USD except per share items
Portfolio Optimizer

Find the right allocation for ONCT and SAGE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer